News

Recent reviews highlight that melanoma risk associated with occupational UV exposure varies by tumor subtype, anatomical site, and individual susceptibility.

A split-face trial finds adding ivermectin to KTP laser modestly boosts rosacea redness reduction and cuts papules/pustules, without extra downtime.

Compared with topical regimens, Rossi notes PDT provides a shorter recovery window and fewer adherence challenges.

Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed clinical cases highlighting the distinct roles of topical ruxolitinib, tapinarof, and roflumilast in managing itch, inflammation, and long-term disease control in atopic dermatitis.

Mark Lebwohl, MD, discusses how the 487-GEP test may help clinicians identify the most appropriate systemic therapy for patients with AD earlier in the treatment journey.

A multicenter trial in China shows ALA-PDT clears Bowen’s disease in 97% with low recurrence, minimal scarring, and high patient satisfaction.

Researchers observed early reductions in acne lesions, with improvements beginning within 5 days of dermocosmetic treatment in patients with acne.

February highlights rare genetic skin diseases, shifting dermatology from supportive care to molecularly targeted therapies.

Results show that bimekizumab achieved significantly higher ACR50 response rates at week 16 than risankizumab in adults with active PsA.

FDA Fast Track boosts hopes for QRX003 lotion in Netherton Syndrome, with early trials showing rapid skin healing and itch relief.

This review of the latest dermatological studies includes insights on pediatric teledermatology rates pre- and post-COVID, a 10-peptide face serum for skin quality, AI-automated disease scoring, and more.

Needle-free botulinum toxin microjet TDA delivery cuts facial oil up to 40%, refines pores, and boosts confidence without bruising or downtime in acne patients.

A prospective study found that patch testing identified relevant allergens in 43% of patients with hand and foot eczema, with potassium dichromate being the most common sensitizer.

A new study reveals gaps in acne management for teens with PCOS; Hispanic patients are less likely to receive spironolactone, COCs, or isotretinoin treatment.

Red light–activated photodynamic therapy offers an effective field-based option for treating both visible and subclinical actinic keratoses.

Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.

Real-world data show IL-17 biologics rapidly improve special-site psoriasis and quality of life, as researchers identified predictors of PASI75/90 response.

Dylan Timmermann, PA-C, reflects on the experiences that shaped his career trajectory in dermatology and offers insights relevant to physician assistants and nurse practitioners entering the specialty.

A survey of dermatology residents found that interest in subspecialty fellowships often declines during training, with financial concerns particularly affecting pediatric dermatology.

NFBC1966 data from Finland show that hand eczema is associated with poorer self-rated work ability among middle-aged adults, particularly among those with certain risk factors.

Patients treated with deucravacitinib achieved higher ACR20 response rates at week 16 than those receiving placebo in the POETYK PsA studies.

A newly defined Nodularity Index, measuring tumor depth relative to width, independently predicted melanoma-specific survival.

A cover feature by Nicole A. Negbenebor, MD, FAAD, examines the growing leadership role of women in Mohs micrographic surgery for nonmelanoma skin cancer.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

In case you missed it, this week we had news on the end of late-stage rocatinlimab OX40 development, FDA priority review of brepocitinib for dermatomyositis, phase 3 trial data of cemiplimab, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

O’Donoghue, a respected dermatologist and educator, left a lasting impact through her leadership, scholarship, and dedication to family and faith.

In the latest Cutaneous Connection podcast episode, Doris Day, MD, FAAD, offers practical guidance for clinicians looking to incorporate discussions of hormonal health into aesthetic consultations with menopausal patients.

At week 16, 73.3% of patients receiving delgocitinib achieved a clinically meaningful improvement (≥ 4 points) in Dermatology Life Quality Index score vs 47.8% with vehicle.

Explore PDPA’s 2025 compensation survey, revealing dermatology PA salary trends, workload patterns, benefits insights, and job satisfaction across the state of Pennsylvania.